(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -78.08%196 | 62.86%-11.62K | -110.97%-1.49K | -3,650.08%-22.83K | -332.07%-6.02K | 1,802.13%894 | -1,288.07%-31.29K | 5,207.03%13.59K | 102.08%643 | 108.45%2.59K |
Net income from continuing operations | -10.56%-154.01K | -11.78%-152.81K | -11.89%-147.21K | -20.72%-585.93K | -41.81%-178.35K | -11.27%-139.3K | -14.28%-136.71K | -14.64%-131.57K | -5.66%-485.35K | -7.97%-125.76K |
Asset impairment expenditure | ---- | ---- | ---- | --33.25K | ---- | ---- | ---- | ---- | --0 | ---- |
Change In working capital | 9.99%154.21K | 33.93%141.19K | 0.39%145.72K | 9.02%529.85K | 8.35%139.07K | 11.94%140.2K | -10.18%105.42K | 26.20%145.16K | 13.42%485.99K | 49.65%128.36K |
-Change in receivables | -97.71%102 | 99.96%-1 | --0 | -9,333.33%-2.55K | -2,104.00%-2.51K | 63.01%4.46K | -13.92%-2.84K | -321.88%-1.66K | -132.53%-27 | 468.18%125 |
-Change in payables and accrued expense | 13.53%154.1K | 30.42%141.19K | -0.74%145.72K | 9.54%532.39K | 10.41%141.58K | 10.80%135.74K | -9.68%108.26K | 27.20%146.82K | 13.44%486.02K | 30.52%128.23K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -78.08%196 | 62.86%-11.62K | -110.97%-1.49K | -3,650.08%-22.83K | -332.07%-6.02K | 1,802.13%894 | -1,288.07%-31.29K | 5,207.03%13.59K | 102.08%643 | 108.45%2.59K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 19.00%-648 | 0 | -29.8K | 0 | 0 | -800 | -29K | 0 | 0 |
Net PPE purchase and sale | --0 | 19.00%-648 | --0 | ---- | ---- | --0 | ---800 | ---29K | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---29.8K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 19.00%-648 | --0 | ---29.8K | --0 | --0 | ---800 | ---29K | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1K | -57.62%12.93K | 0 | 51.5K | 5K | 0 | 30.5K | 16K | 0 | 0 |
Net issuance payments of debt | ---1K | -57.62%12.93K | --0 | --51.5K | --5K | --0 | --30.5K | --16K | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---1K | -57.62%12.93K | --0 | --51.5K | --5K | --0 | --30.5K | --16K | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -47.67%1.05K | -88.95%398 | -37.38%1.89K | 27.11%3.02K | 590.74%2.91K | 438.50%2.01K | 37.02%3.6K | 27.11%3.02K | 23.48%2.37K | -76.48%421 |
Current changes in cash | -189.93%-804 | 141.34%656 | -354.27%-1.49K | -275.27%-1.13K | -139.32%-1.02K | 1,802.13%894 | 29.59%-1.59K | 128.91%586 | 42.57%643 | 345.70%2.59K |
End cash Position | -91.40%250 | -47.67%1.05K | -88.95%398 | -37.38%1.89K | -37.38%1.89K | 590.74%2.91K | 438.50%2.01K | 37.02%3.6K | 27.11%3.02K | 27.11%3.02K |
Free cash from | -78.08%196 | 61.76%-12.27K | 90.33%-1.49K | -3,650.08%-22.83K | 816.73%23.78K | 1,802.13%894 | -1,323.56%-32.09K | -6,121.09%-15.41K | 102.08%643 | 108.45%2.59K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.